Treatment of the diabetic foot – to amputate or not?

BMC Surgery

Pius Fokam¹  Elroy P Weledji¹ 

[1] Department of Surgery, Faculty of Health Sciences, University of Buea, PO Box 126, Limbe, S W Region, Cameroon

关键词: Amputation;    Treatment;    Ischaemia;    Neuropathy;    Infection;    Diabetic foot;   

Others  :  1091587
DOI  :  10.1186/1471-2482-14-83

 received in 2014-02-02, accepted in 2014-10-14,  发布年份 2014

【 摘 要 】

Background

Diabetic foot infections are a frequent clinical problem. About 50% of patients with diabetic foot infections who have foot amputations die within five years. Properly managed most can be cured, but many patients needlessly undergo amputations because of improper diagnostic and therapeutic approaches.

Discussion

The article debates the pros and cons of amputation of the diabetic foot. The thesis is that if the guidelines on the management of the diabetic foot are followed primary amputation is only necessary for the unsalvageable diabetic foot. This approach would reduce the incidence of lower limb amputations in diabetic patients.

Summary

We favour the argument that a structured clinical and vascular assessment would help clinical decision- making as to which patients to hospitalize, which to send for imaging, or for whom to recommend surgical interventions. Endovascular procedures are the future in the treatment of diabetic arterial disease and hence the diabetic foot.

【 授权许可】

   
2014 Weledji and Fokam; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E: Infectious diseases society of America. Clinical practice guidelines for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 54:132-73.
• [2]Becks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucacianpopulation : the Hoorn study. Diabetologia 1995, 38(1):163-166.
• [3]Schaper NC, Apelqvist J, Bakker K: The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 2003, 3:475-9.
• [4]Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS: Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004, 39:885-910.
• [5]Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, van Baal J, van Merode F, Schape N: High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007, 50:18-25.
• [6]Oyibo SO, Jude EB, Tarawinch I, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ: A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001, 24(1):84-88.
• [7]Schaper NC: Diabetic foot ulcer classification system for research purposes; a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004, 20(Supp1):390-5.
• [8]Singh N, Armstrong DG, Lipsky B: Preventing foot ulcers in patients with diabetes. JAMA 2005, 293:217-28.
• [9]Callum KG: Below knee amputation. Curr Pract Surg 1992, 4:20-24.
• [10]Hirsh AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, William RC, Murphy WR, Jeffrey W, Olin JW, Puschett JB, Kenneth A, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, John White J, White RA: ACC/AHA practice guidelines for the management of patients with peripheral arterial disease. Circulation 2006, 113:e463-6.
• [11]Bargellini I, Piaggesi A, Cicorelli A, Rizzo L, Cervilli R, Iacopi E, Lunardi A, Cioni R: Predictive value of angiographic scores for the integrated management of the ischaemic diabetic foot. J Vasc Surg 2013, 57:1204-12.
• [12]Pinzur MS, Pinto MA, Schon LC, Smith DG: Controversies in amputation surgery. Instr Course Lect 2004, 52:445-51. 39(Suppl 2):S123-8
• [13]Sumpio BE, Lee T, Blummet A: Vascular evaluation and arterial reconstruction of the diabetic foot. Clin Podiatr Med Surg 2003, 20:689-708.
• [14]Khan NA, Rahim SA, Anand SS, Simel DL, Panju A: Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 2006, 295:536-46.
• [15]van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Ferreira I, Huijberts M: Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 2011, 28:199-205.
• [16]Gibbons GW: Lower extremity bypass in patients with diabetic foot ulcers. Surg Clin North Am 2003, 83:659-69.
• [17]Faglia E, Clerici G, Losa S, Tavano D, Cammiti M, Miramonti M, Somalvico F, Airoldi F: Limb revascularization feasibility in diabetic patients with critical ischaemia: results from a cohort of 344 consecutive unselected diabetic patients evaluated in 2009. Diabetes Res Clin Pract 2012, 95:364-71.
• [18]Armstrong DG, Wrobel J, Robbins JM: Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007, 4:286-7.
• [19]Tan T, Shaw EJ, Siddiqui F, Kandaswamy P, Barry PW, Baker M: Inpatient management of diabetic foot problems: summary of NICE guidance. BMJ 2011, 342:1280.
• [20]Richard JL, Lavigne JP, Got I, Hartemann A, Malgrange D, Tsirtsikolou D, Baleydier A, Senneville E: Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study. Diabetes Metab 2010, 37:208-15.
• [21]Pecorano RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation. Basis for prevention. Diabetic Care 1990, 13(5):513-521.
• [22]Trautner C, Haastert B, Mauckner P, Gatcke LM, Giani G: Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990–2005: results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 2007, 30:2633-7.
• [23]Krishnan S, Nash F, Baker N, Fowler D, Rayman G: Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008, 31:99-101.
• [24]Chaytor ER: Surgical treatment of the diabetic foot. Diabetes Metab Res Rev 2000, 16(Suppl 1):S66-9.
• [25]Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA: Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 2009, 83:347-52.
• [26]Goven MF, Karibiber A, Kaynak G, Oyet T: Conservative and surgical treatment of the chronic Charcot foot and ankle. Diabetic Foot Ankle 2013. In press
• [27]Bridges RM Jr, Deitch EA: Diabetic foot infections. Pathophysiology and treatment. Surg Clin North Am 1994, 7(4):537-55.
• [28]Prompers L, Schaper N, Apelqvist J, Edmonds F, Jude E, Mauricio D, Uccoli L, Urbanci V, Bakker K, Holstein B, Jirkovska A, Piaggesi A, Jirkovska A, Ragnaeson-Tennrall G, Reike H, Spraul M, VanAcker K, Van Baal J, Van Merode F, Ferriera I, Huijbets M: Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 2008, 51:747-55.
• [29]Cheo JJ, Tan SB, Sivathasan C, Pavanni R, Tan SK: Vascular assessment in the neuropathic diabetic foot. Cln Orthop Relat Res 1995, 320:95-100.
• [30]Piaggesi A, Schipani E, Campi F, Romanelli M, Baccetti F, Arvia C, Navalesi R: Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med 1998, 15:412-7.
• [31]Shogalefard A, Khorgami Z, Mologen-Tehrain MR, Langam B: Large and deep diabetic heel ulcers need not lead to amputation. Foot Ankle Int 2013, 34:215-21.
• [32]Lipsky BA, Sheehan P, Armstrong DG, Tice AD, Polis AB, Abramson MA: Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 2007, 4:30-8.
• [33]Vermeulen H, Ubbink D, Goossens A, de Vos R, Legemate D: Dressings and topical agents for surgical wounds healing by secondary intention. Cochrane Database Syst Rev 2004, 2:CD003554.
• [34]Weledji EP, Kamga HLF, Assob JC, Nsagha DS: A critical review of HIV/AIDS and wound care. Afr J Cln Exper Microbiol 2012, 13(2):66-73.
• [35]Nelson EA, O’Meara S, Golder S, Dalton J, Craig D, Iglesias C, DASIDU Steering Group: Systematic review of antimicrobial treatments for diabetic foot ulcers. Diabetic Med 2006, 23(4):348-359.
• [36]Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H: Topical silver for preventing wound infection. Cochrane database. Syst Rev 2010, 17(3):CD066478.
• [37]Madhok BM, Vowden K, Vowden P: New techniques for wound debridement. Int Wound J 2013, 10(3):247-51.
• [38]Nian- Feng S, Ai-Ling T, Yu-Ling T, San-yuan H, Li X: The interventional therapy for diabetic peripheral artery disease. BMC Surg 2013, 13:32. BioMed Central Full Text
• [39]Stone PA, Back MR, Armstrong PA, Flaherty SK, Keeling WB, Johnson BL, Shames ML, Bandyk DF: Midfoot amputations expand limb salvage rates for diabetic foot infections. Ann Vasc Surg 2005, 19(6):805-11.
• [40]Giummarra MJ, Gibson SJ, Georgion-Karistinis N, Bridshaw JC: Central mechanisms in phantom limb perception: the past, present and furure. Brain Res Rev 2007, 54:219-23.
• [41]Ramachandran VS, Hirstein W: The perception of phantom limbs. ‘The D.O.Hebb Lecture”. Brain: J Neurol 1998, 121(9):1603-1630.
• [42]Wrobel JS, Robbins J, Armstrong DG: The high-low amputation ratio: a deeper insight into diabetic foot care. J Foot Ankle Surg 2006, 45:375-9.